Delighted that 4Degra has been selected as a finalist for the TCT Materials Award! Winners will be recognised on the evening of June 8th during a formal awards ceremony hosted by television presenter and tech enthusiast Jason Bradbury at Hilton Birmingham Metropole. TCT Awards celebrates the world’s leading innovations and innovators within the 3D printing and …
‘3D printing and regenerative medicine with 4D Biomaterials’ – Interview conducted at formnext, Frankfurt with 3D Printing Industry.
Partnership Enables Uncharted Micro 3D Printing Applications for BMF’s Medical Device Manufacturing Customers Boston, MA and Nottingham, UK – 7 December 2021 – Boston Micro Fabrication (BMF), the pioneer in microscale 3D printing systems and UK-based 3D printing materials company, 4D Biomaterials today announce the capability to print micro-scale geometries using 4Degra® bioresorbable materials. This …
Rapid Shape and 4DBiomaterials® team up to evaluate medical device applications with new bioresorbable 3D printing resins using next generation vat polymerization technology Formnext, 16 November 2021 – Rapid Shape is evaluating a partnership between its vat polymerization 3D printing technology and a new class of bioresorbable materials trademarked 4Degra® from 4D Biomaterials®. A UK-based …
See 4D Biomaterials® at the world’s largest event for additive manufacturing and 3D printing, FormNext, Frankfurt am Mein, Germany, 16-19 November. Hall 11 Stand B59. We will be announcing an exciting new partnership programme for 3D printing hardware vendors and medical device innovators, demonstrating the ground-breaking performance of structures made with 4Degra® resins and showing a range of implantable medical …
4D Biomaterials is delighted to announce the world’s first public appearance of the 4Degra™ product range at the UK’s foremost Med-Tech trade event. Our team will be demonstrating the ground-breaking performance of 3D printed structures made with 4Degra™ and showing examples of the implantable medical devices that are being developed from them. We look forward …
4D Biomaterials® has just completed a £1.6m ($2.2m) seed investment round led by DSW Ventures and backed by the MEIF Proof of Concept and Early Stage Fund which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s own funds, and existing investor SFC Capital. The company’s leading product 4Degra™ can be …
4D Biomaterials – so what’s new? An interview with Phil Smith is featured on the 3D Medtech Printing Conference website, read the interview here 3D Medical Printing Series: LinkedIn View the LinkedIn Event Activity here Facebook Activity View the Facebook Event Activity here 4D Biomaterials is introducing a new class of 3D printing resin-inks for …
Are you looking to invest in disruptive new MedTech technology with the potential to become a substantial medical device/materials business? Building on the rapid progress made in our first nine months of operation, we are now seeking seed investment of £1m that will enable the company to hit the next set of milestones on our …
Universities of Birmingham and Warwick form spinout company, 4D Medicine Ltd, to take new family of biomedical 3D printing resins to market